Kinnevik AB (publ)
- SEC CIK
- 0001766574
- Latest filing
- Nov 4, 2025
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 1, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 3
- +1 vs. Q3 2022
- Portfolio value
- $177.3M
- +$58.0M (+48.6%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TDOCTeladoc Health, Inc. | COM | 3,683,668 | $87.1M | 49.1% | 00.0% | Unchanged | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 7,653,061 | $59.0M | 33.3% | +7,653,061 | New | History |
| Babylon Hldgs LtdG07031100 | CL A SHS | 4,617,340 | $31.2M | 17.6% | −50,325,228−91.6% | Reduced | – |